Source: Virtual Congress 2020 – Aspergillosis and chronic lung infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Chiron (Montpellier Cedex 5, France), N. Veziris (Paris, France), C. Andrejak (Amiens, France), W. Hoefsloot (Nijmegen, Netherlands), Z. Aoun (Beirut, Lebanon), C. Audoly (Marseille, France), D. Basille (Amiens, France), A. Benattia (Paris, France), A. Bergeron (Paris, France), J. Bervar (Lille, France), J. Boitiaux (Pontoise, France), A. Bourdin (Montpellier, France), D. Bouvry (Paris, France), J. Cadranel (Paris, France), G. Chatté (Caluire, France), L. Colombain (Perpignan, France), J. Couderc (Suresnes, France), B. Crestani (Paris, France), J. Crouzet (Nimes, France), G. Deslee (Reims, France), B. Douvry (Créteil, France), M. Drevait (Montpellier, France), M. Dupuy Grasset (Limoges, France), S. Jouneau (Rennes, France), M. Kerjouan (Rennes, France), S. Leroy (Nice, France), T. Maitre (Paris, France), J. Mallet (Montpellier, France), M. Massongo (Yaounde, Cameroon), M. Murris Espin (Toulouse, France), A. Payet (La Réunion, France), P. Pradère (Clamart, France), A. Prevotat (Lille, France), C. Rogé (Morlaix, France), F. Schlemmer (Paris, France), L. Slim (Ariana, Tunisia), C. Toper (Saint Cloud, France), F. Tritar (Ariana, Tunisia), M. Patrizi (Paris AP HP, France), V. Bouix (Alès, France), F. Blanc (Nantes, France), E. Catherinot (Suresnes, France). An expert statment on clinical considerations before treating NTM lung infection. 2315

Member's Comments

No comment yet.

Related content which might interest you: Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Guideline 2020 Year: 2020 Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline Source: Eur Respir J, 56 (1) 2000535; 10.1183/13993003.00535-2020 Year: 2020 Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease Source: Eur Respir J, 53 (5) 1801636; 10.1183/13993003.01636-2018 Year: 2019 Identification and management of non tuberculous mycobacteria in extra pulmonary cases in clinical practice Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009 The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008 Radiological evidence of lung damage in patients not fulfilling accepted microbiologic criteria for treatment of nontuberculous mycobacteria Source: Annual Congress 2010 - Nontuberculous mycobacterial infections and tuberculosis Year: 2010 IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement Source: Eur Respir J, 51 (3) 1800170; 10.1183/13993003.00170-2018 Year: 2018 I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas! Year: 2009 Immunological response in HIV-associated tuberculosis and the implications of HIV in the search for a tuberculosis vaccine Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news? Year: 2007 Slow-growing lung cancer as an emerging entity: from screening to clinical management Source: Eur Respir J 2013; 42: 1706-1722 Year: 2013 Clinical features of invasive pulmonary aspergillosis in critically ill patients with chronic respiratory diseases: a perspective study Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Identification of potentially undiagnosed patients with nontuberculous mycobacterial lung disease using machine learning applied to primary care data in the UK Source: Eur Respir J, 56 (4) 2000045; 10.1183/13993003.00045-2020 Year: 2020 New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Source: ERS Webinar 2020: New international (ATS/ERS/ESCMID/IDSA) guidelines for the management of NTM pulmonary diseases Year: 2020 Non tuberculous mycobacteria lung infection. Study of 31 cases and review of the literature Source: Eur Respir J 2004; 24: Suppl. 48, 644s Year: 2004 Ocular manifestations in unselected group of sarcoid patients hospitalised in the national tuberculosis and lung diseases research institute Source: Eur Respir J 2002; 20: Suppl. 38, 435s Year: 2002 Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011